PALB2 and breast carcinoma: In addition, only one out of the four PALB2-associated breast cancers with mono-allelic PALB2 alterations displayed a dominant mutational signature 3, whereas eight out of 12 PALB2-associated breast cancers with bi-allelic PALB2 inactivation harbored a dominant mutational signature 3.